Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study.
The Lancet regional health. Europe
View this publicationDepartment of Psychiatry and Psychotherapy, University of Cologne
Kerpener Str. 62, 50931 Cologne
The main objective of Dr. Ramirez’s laboratory is the identification of the genetic and epigenetic architecture that influences the disease processes underlying cognitive disorders such as Alzheimer’s disease. A key focus of his research is identifying the molecular mechanisms at the intersection of ageing and Alzheimer’s disease that drive cognitive decline. His group combines (epi)genomics and proteomics to study cellular senescence, a key mechanism that triggers chronic inflammation through the senescence-associated secretory phenotype (SASP).
